CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
Embosphere microparticles for prostate artery embolizationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03055624
NCT03055624N/ACompleted
CompareCT.gov

Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia

University of California, San Diego·interventional·Posted Feb 16, 2017·Updated Mar 31, 2020

In Brief

A clinical study evaluating Embosphere microparticles for prostate artery embolization for Prostatic Hyperplasia, Benign and Enlarged Prostate With Lower Urinary Tract Symptoms. Completed, enrolled 9 participants across 1 site.

Detailed Summary

Investigator-initiated study to evaluate the safety and efficacy of prostate artery embolization for the treatment lower urinary tract symptoms in patients with benign prostatic hyperplasia

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstatic Hyperplasia, Benign, Enlarged Prostate With Lower Urinary Tract Symptoms
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 16, 2017
Enrollment StartMar 1, 2017
Primary CompletionFeb 18, 2019
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 9.4 years ago

Interventions

Embosphere microparticles for prostate artery embolizationdevice

Pelvic angiograms will be performed and microspheres delivered to the arteries supplying the prostate to alleviate symptoms of benign prostatic hyperplasia.